Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atezolizumab and Bevacizumab in Hepatocellular Carcinoma”

83 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 83 results

Testing effectiveness (Phase 2)Looking for participantsNCT06819566
What this trial is testing

Prophylactic Endoscopic Variceal Ligation in Patients With High-risk Esophageal Varices Receiving Atezo/Bev for HCC

Who this might be right for
Hepatocellular CarcinomaEsophageal VarixBleeding Esophageal Varices
Asan Medical Center 44
Testing effectiveness (Phase 2)Ended earlyNCT05776875
What this trial is testing

Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCC

Who this might be right for
Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma
Yale University 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018947
What this trial is testing

Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

Who this might be right for
Resectable Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT05211323
What this trial is testing

Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

Who this might be right for
Combined Hepatocellular Carcinoma and CholangiocarcinomaStage III Liver CancerStage IV Liver Cancer
National Cancer Institute (NCI) 88
Not applicableLooking for participantsNCT05763277
What this trial is testing

Ate-Bev Early Response Prediction Model in Advanced HCC

Who this might be right for
Hepatocellular CarcinomaAtezolizumab-bevacizumabResponse Evaluation
Seoul National University Hospital 170
Not applicableLooking for participantsNCT07365930
What this trial is testing

NIS on the Benefits of TIPS in Patients With HCC Receiving Atezo+Bev in 1st-Line Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 350
Testing effectiveness (Phase 2)UnknownNCT05134532
What this trial is testing

Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
CHA University 40
Testing effectiveness (Phase 2)Study completedNCT04170556
What this trial is testing

Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)

Who this might be right for
Hepatocellular Carcinoma
Fundacion Clinic per a la Recerca Biomédica 69
Not applicableUnknownNCT05879328
What this trial is testing

The ImmunoXXL Study

Who this might be right for
Hepatocellular Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04563338
What this trial is testing

An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

Who this might be right for
Hepatocellular CarcinomaNon-small Cell Lung Cancer MetastaticLiver Metastases
University Health Network, Toronto 36
Testing effectiveness (Phase 2)Looking for participantsNCT07246668
What this trial is testing

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsCarcinoma+1 more
Yonsei University 52
Not applicableNot Yet RecruitingNCT07109336
What this trial is testing

Development and Prospective Validation of a Heterogeneous Treatment Effect-Based Decision Model for Transarterial Chemoembolization Combined With or Without Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Who this might be right for
HCC - Hepatocellular Carcinoma
Zhongda Hospital 790
Testing effectiveness (Phase 2)Ended earlyNCT05537402
What this trial is testing

LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCC

Who this might be right for
Hepatocellular Carcinoma
University of Texas Southwestern Medical Center 1
Early research (Phase 1)Active Not RecruitingNCT05097911
What this trial is testing

Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.

Who this might be right for
Advanced Hepatocellular Carcinoma
National University Hospital, Singapore 33
Testing effectiveness (Phase 2)Study completedNCT05101629
What this trial is testing

Pembrolizumab and Lenvatinib in Patients With Advanced HCC Who Are Refractory to Atezolizumab and Bevacizumab/ IO-based Therapy

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 32
Large-scale testing (Phase 3)Ended earlyNCT04732286
What this trial is testing

Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 100
Testing effectiveness (Phase 2)Looking for participantsNCT04727307
What this trial is testing

Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Montpellier 202
Not applicableStudy completedNCT04862949
What this trial is testing

Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma
CHA University 131
Testing effectiveness (Phase 2)UnknownNCT05396937
What this trial is testing

Efficacy and Safety of T+A+RAD in HCC

Who this might be right for
Hepatocellular Carcinoma
Fudan University 42
Large-scale testing (Phase 3)Looking for participantsNCT04803994
What this trial is testing

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 434
Load More Results